Cefotaxime lock improves survival of tunneled cuffed hemodialysis catheters in diabetics
This article has no abstract so we have provided the first paragraph of the full text.
Tunneled cuffed catheters (TCCs) are frequently the only vascular access option for hemodialysis patients with diabetes, because of these patients' compromised vasculature. TCCs are, however, vulnerable to bacterial infection and thrombogenesis. Saxena et al. assessed the efficacy of the cephalosporin cefotaxime as an antibiotic lock in preventing TCC-related infection and thrombosis in hemodialysis patients with diabetes.
Full text of this article is available with one of the following:
- Membership of the International Society of Nephrology. If already a member, please login. If not please join the Society now
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please login for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or login above.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Mathematical physics Added dimensions to grain growthNature News and Views (26 Apr 2007)
Applied physics Weight insideNature News and Views (26 Apr 2007)
